pentamethylmelamine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, DA | 1 |
| Casper, ES; Gordon, C; Gralla, RJ; Jones, BR; Kelsen, DP; Lynch, GR; Woodcock, TM; Young, CW | 1 |
2 other study(ies) available for pentamethylmelamine and Lung Neoplasms
| Article | Year |
|---|---|
Hexamethylmelamine and pentamethylmelamine: an update.
Topics: Altretamine; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Lung Neoplasms; Male; Ovarian Neoplasms; Prostatic Neoplasms; Triazines | 1983 |
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Triazines; Vomiting | 1981 |